Department of Global Health, University of Washington, 325 Ninth Avenue, Seattle, Washington, 98104, USA.
Partners in Health and Research Development, Nairobi, Kenya.
AIDS Behav. 2021 Dec;25(12):3871-3882. doi: 10.1007/s10461-021-03229-5. Epub 2021 Apr 7.
As countries scale up pre-exposure prophylaxis (PrEP) for HIV prevention, diverse PrEP delivery models are needed to expand access to populations at HIV risk that are unwilling or unable to access clinic-based PrEP care. To identify factors that may influence implementation of retail pharmacy-based PrEP delivery in Kenya, we conducted in-depth interviews with 40 pharmacy clients, 16 pharmacy providers, 16 PrEP clients, and 10 PrEP providers from two provinces. Most participants expressed strong support for expanding PrEP to retail pharmacies, though conditioned their acceptance on assurances that care would be private, respectful, safe, and affordable. Participant-reported determinants of feasibility centered primarily on ensuring that the intervention is compatible with retail pharmacy operations (e.g., staffing levels, documentation requirements). Future research is needed to develop and test tailored packages of implementation strategies that are most effective at integrating PrEP delivery into routine pharmacy practice in Kenya and other high HIV prevalence settings.
随着各国扩大用于预防艾滋病毒的暴露前预防（PrEP），需要多样化的 PrEP 提供模式，以扩大获得艾滋病毒风险人群的机会，这些人群不愿意或无法获得基于诊所的 PrEP 护理。为了确定可能影响肯尼亚基于零售药店的 PrEP 提供的实施因素，我们对来自两个省份的 40 名药店客户、16 名药店提供者、16 名 PrEP 客户和 10 名 PrEP 提供者进行了深入访谈。大多数参与者强烈支持将 PrEP 扩大到零售药店，但前提是要确保护理是私密、尊重、安全和负担得起的。参与者报告的可行性决定因素主要集中在确保干预措施与零售药店的运营相兼容（例如，人员配备水平、文件要求）。需要进一步研究制定和测试有针对性的实施策略包，以最有效地将 PrEP 提供纳入肯尼亚和其他高艾滋病毒流行地区的常规药店实践。
